Last updated: N/A
Sponsor: N/A
Overall Status: Active - Recruiting
Phase
1
Condition
Schizophrenia And Schizoaffective Disorders
Treatment
N/AClinical Study ID
TX212764
Ages 18-55 All Genders
Study Summary
Eligibility Criteria
Inclusion
- Males and Females, ages 18-55
- Diagnosed with Schizophrenia
- Taking medication for schizophrenia at a stable dose for at least 2 months
Study Design
Study Start date:
Estimated Completion Date: